Investing Profile

Karl Handelsman(204)

CEO

Founder & Investor at Codon Capital

codoncapital.com/about.htmlSan Francisco, California

Your Intro Paths to Karl Handelsman

Signal uses Gmail to reveal intro paths. Email content is never read.

Karl Handelsman's investing connections

Connected to 9 investors on Signal.

Networks Karl is a member of

Stanford University Network

500 CONNECTIONS

MIT Sloan School of Management Network

237 CONNECTIONS

Boston University Network

153 CONNECTIONS

Massachusetts Institute of Technology - Sloan School of Management Network

81 CONNECTIONS

Genentech Network

75 CONNECTIONS

Find Karl Handelsman on

Current Investing Position

Codon Capital Investor

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Karl Handelsman is on these Sector & Stage Rankings

AgTech (Series B)Consumer Health (Series B)AgTech (Series A)BioTech (Series B)AgTech (Seed)Consumer Health (Series A)BioTech (Seed)Consumer Health (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay Area Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Karl Handelsman's Investments On Record (3)

Company	StageDateRound Size	Total Raised
Bonum Therapeutics	Series ANov 2022$93M	$93M
Co-investors: John McKearn (RiverVest Venture Partners), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Good Therapeutics	Series AFeb 2019$11M	$30M
Co-investors: John McKearn (RiverVest Venture Partners), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Clear Labs	Series BOct 2018$21M	$170M
Co-investors: Aydin Senkut (Felicis Ventures), Krishna Yeshwant (GV (Google Ventures)), Greg Yap (Menlo Ventures), Chris Sklarin (Castor Ventures (an Alumni Ventures Fund)), Miguel Valls (Alta Life Sciences), Kyle Kurpinski (Tencent Holdings)

Karl Handelsman's Experience

Member Life Science Angels2014 - Present

Catalyst Advisory Panel UCSF2013 - Present

SPARK Selection Committee Stanford University2013 - Present

Founder & Investor Codon Capital2013 - Present

Director, Business Development Takeda OncologyPresent

Lean Launchpad for Therapeutics/Tools Instructor CMEA CapitalPresent

Lean Launchpad for Therapeutics/Tools Instructor University of California, San FranciscoPresent

Mentor CMEA CapitalPresent

Catalyst Advisory Panel CMEA CapitalPresent

Catalyst Advisory Panel University of California, San FranciscoPresent

Senior Advisor, Roche Venture Fund Genentech2016 - 2021

Mentor California Inst. for Regenerative Medicine2013 - 2016

Lean Launchpad for Therapeutics/Tools Instructor UCSF2013 - 2016

General Partner Emeritus CMEA Capital2013 - 2014

Managing Director/General Partner CMEA Capital1999 - 2013

Director, Business Development Millennium Pharmaceuticals1996 - 1997

Manager, Business Development Tularik1992 - 1996

Karl Handelsman's Education

Boston University Bachelor of Arts (B.A.) Biology, General & Physics

Harvard Medical School Master of Science (M.S.) Genetics

MIT Sloan School of Management Master of Business Administration (MBA) Business Administration and Management, General

Massachusetts Institute of Technology - Sloan School of Management Master of Business Administration (MBA) Business Administration and Management, General

Investors who invest with Karl Handelsman

Scouts & Angels Affiliated With Karl Handelsman